CA 2729 CA 153 Breast Cancer Markers Panel Test
Introduction to the Test
The CA 2729 CA 153 Breast Cancer Markers Panel Test is a vital diagnostic tool designed to detect specific markers associated with breast cancer. This test plays a significant role in the early diagnosis and management of breast cancer, providing essential information that can aid healthcare professionals in making informed decisions regarding patient care.
What the Test Measures
This test measures the levels of cancer antigen 27.29 (CA 27.29) and cancer antigen 15.3 (CA 15.3) in the blood. Elevated levels of these markers can indicate the presence of breast cancer or the recurrence of the disease in individuals who have previously been diagnosed.
Who Should Consider This Test?
This test is recommended for:
- Individuals with a family history of breast cancer.
- Patients experiencing symptoms such as unexplained weight loss, lumps in the breast, or changes in breast shape.
- Women who have previously been treated for breast cancer and require monitoring for recurrence.
Benefits of Taking the Test
The benefits of the CA 2729 CA 153 Breast Cancer Markers Panel Test include:
- Early detection of breast cancer, which can lead to more effective treatment options.
- Monitoring treatment effectiveness in patients already diagnosed with breast cancer.
- Providing oncologists and gynecologists with critical data to guide patient management.
Understanding Your Results
Results from the CA 2729 CA 153 Breast Cancer Markers Panel Test will typically be available within 2 to 3 weeks. It is essential to discuss your results with a healthcare provider who can interpret the findings in the context of your overall health and medical history.
Test Pricing
Price Type | Amount (KSh) |
---|---|
Discount Price | 26,000 |
Regular Price | 36,000 |
Branches and Booking
We have branches across major cities in Kenya, including Nairobi, Mombasa, and Kisumu. Additionally, we offer home sample collection services for your convenience. To book the CA 2729 CA 153 Breast Cancer Markers Panel Test, please call or WhatsApp us at +254711564616.
Test Details
Turnaround Time: Sample by 7th of the month; report after 2 to 3 weeks.
Sample Type: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Provide brief clinical history.
Pre-Test Instructions: Provide brief clinical history.
Method: CMIA, Immunoassay.
Specialties: Oncologist, Gynecologist.
Don’t wait for symptoms to appear. Early detection is key to effective treatment. Book your test today!